Roles of the Polyphenol–Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Accumulating evidence indicates that the gut microbiota can promote or inhibit colonic inflammation and carcinogenesis. Promotion of beneficial gut bacteria is considered a promising strategy to alleviate colonic diseases including colitis and colorectal cancer. Interestingly, dietary polyphenols, which have been shown to attenuate colitis and inhibit colorectal cancer in animal models and some human studies, appear to reach relatively high concentrations in the large intestine and to interact with the gut microbial community. This review summarizes the modulatory effects of polyphenols on the gut microbiota in humans and animals under healthy and diseased conditions including colitis and colitis-associated colorectal cancer (CAC). Existing human and animal studies indicate that polyphenols and polyphenol-rich whole foods are capable of elevating butyrate producers and probiotics that alleviate colitis and inhibit CAC, such as Lactobacillus and Bifidobacterium. Studies in colitis and CAC models indicate that polyphenols decrease opportunistic pathogenic or proinflammatory microbes and counteract disease-induced dysbiosis. Consistently, polyphenols also change microbial functions, including increasing butyrate formation. Moreover, polyphenol metabolites produced by the gut microbiota appear to have anticancer and anti-inflammatory activities, protect gut barrier integrity, and mitigate inflammatory conditions in cells and animal models. Based on these results, we conclude that polyphenol-mediated alteration of microbial composition and functions, together with polyphenol metabolites produced by the gut microbiota, likely contribute to the protective effects of polyphenols on colitis and CAC. Future research is needed to validate the causal role of the polyphenol-gut microbiota interaction in polyphenols' anti-colitis and anti-CAC effects, and to further elucidate mechanisms underlying such interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 1×
“Nevertheless, with the recent advances in microbiome analysis (184), it is foreseeable that rigorous identification of species or strains will be achieved through optimized maker gene amplification methods (185), and advanced algorithms for sequencing error correction (186) and taxonomic classification (187).”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 1×
“In the future, investigation of shared microbial functional outcomes between animals and humans and utilization of humanized animals inoculated with human gut microbiota may help obtain clinically relevant data for the translation of basic discovery to humans (195, 196).”
BackgroundKostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · cited 1×
“nucleatum, a commensal-turned pathogenic bacterium, has been reported to be elevated in the colonic biopsies of IBD patients (120) and is believed to promote colorectal carcinogenesis (121, 122).”
BackgroundRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Chemistry and biochemistry of dietary polyphenols
Tsao, R. (2010) · Nutrients · doi:10.3390/nu2121231 · Cited by 2,415 · cited 1×
“Structurally, they are characterized by phenolic moieties and can be roughly classified into phenolic acids, flavonoids, phenolic amides, and others such as stilbenes and lignans (18).”
BackgroundIntestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Diet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257
Best practices for analysing microbiomes
Knight, R., Vrbanac, A., Taylor, B. C., Aksenov, A., Callewaert, C., Debelius, J., Gonzalez, A., Kosciolek, T., McCall, L.-I., McDonald, D., et al. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0029-9 · Cited by 2,030 · cited 1×
“Nevertheless, with the recent advances in microbiome analysis (184), it is foreseeable that rigorous identification of species or strains will be achieved through optimized maker gene amplification methods (185), and advanced algorithms for sequencing error correction (186) and taxonomic classification (187).”
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · cited 2×
“Mechanistically, IBD patients are exposed to excessive oxidative stress, which can promote DNA mutation and potentially lead to activation of oncogenes, disruption of tumor suppressor genes, and promotion of genomic instability (5, 6).”
BackgroundWu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482
How informative is the mouse for human gut microbiota research?
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Interaction between Phenolics and Gut Microbiota: Role in Human Health
Selma, M. V., Espín, J. C., & Tomás-Barberán, F. A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902107d · Cited by 1,324
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287 · cited 1×
“Specifically, CRC patients have been reported to have reduced relative abundance of butyrate producers including Roseburia and Lachnospiraceae bacterium A2, and increased abundance of Enterococcus, Escherichia/Shigella, and Streptococcus, which may contain opportunistic pathogen species (41).”
BackgroundParamsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276 · cited 1×
“(53) performed an 8-wk FMT with stool samples from healthy donors to ulcerative colitis patients and observed significant improvement in steroid-free clinical remission and response rate in treated patients compared with those receiving FMT with the placebo controls.”
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105 · cited 1×
“Interestingly, these pathobionts are enriched in colonic mucosal biofilms of familial adenomatous polyposis (57) and in sporadic CRC patients (58).”
BackgroundDysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063 · cited 1×
“Additionally, in Crohn’s disease patients, microbial dysbiosis is characterized by decreased abundance of Dialister invisus, Clostridium cluster XIVa, Faecalibacterium prausnitzii, and Bifidobacterium adolescentis and increased relative abundance of Ruminococcus gnavus compared with healthy subjects (42).”
BackgroundFat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982
Chlorogenic Acid and Caffeic Acid Are Absorbed in Humans
Olthof, M. R., Katan, M. B., & Hollman, P. C. H. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.1.66 · Cited by 975
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777 · cited 1×
“Since the gut microbiota are believed to play regulatory roles in colitis and CRC development (36, 37), we reason that polyphenols may alleviate colitis and inhibit cancer development, at least in part, via interacting with the gut microbial community.”
BackgroundFurrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766 · cited 1×
“, multiple clinical trials and animal studies have demonstrated their anti-colitis effects in the form of fermented milk products (153), synbiotics (154, 155), or single strains (156), while their anti-CAC effects were observed in animal models either alone (157) or mixed with other Lactobacillus strains (158, 159).”
BackgroundCommensal clostridia: Leading players in the maintenance of gut homeostasis
Lopetuso, L. R., Scaldaferri, F., Petito, V., & Gasbarrini, A. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-23 · Cited by 753
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Singh, R., Chandrashekharappa, S., Bodduluri, S. R., Baby, B. V., Hegde, B., Kotla, N. G., Hiwale, A. A., Saiyed, T., Patel, P., Vijay-Kumar, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07859-7 · Cited by 713
Microbiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Wong, S. H., Zhao, L., Zhang, X., Nakatsu, G., Han, J., Xu, W., Xiao, X., Kwong, T. N. Y., Tsoi, H., Wu, W. K. K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.022 · Cited by 634 · cited 1×
“For instance, fecal microbiota transplantation (FMT) of stool samples from CRC patients is found to promote AOMinduced high-grade dysplasia, multiplicity of macroscopic polyps, elevation of cytokines, and immune cell infiltration in mice compared with those fed stool samples from healthy volunteers (50).”
BackgroundKennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602 · cited 1×
“The lack of or weakening of protective effects in animals without the gut microbiota will support a critical role of the polyphenol– gut microbiota interaction in disease prevention (177).”
BackgroundLarrosa, M., Yañéz-Gascón, M. J., Selma, M. V., González-Sarrías, A., Toti, S., Cerón, J. J., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803638d · Cited by 365 · cited 2×
“coli and Enterobacteria compared with controls (76, 84).”
BackgroundResveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice
Wang, P., Li, D., Ke, W., Liang, D., Hu, X., & Chen, F. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0332-1 · Cited by 301 · cited 1×
“In contrast, supplementation of resveratrol at 300 mg/kg body weight significantly changed microbial composition compared with control diets (85).”
BackgroundProbiotic Strain Lactobacillus casei BL23 Prevents Colitis‐Associated Colorectal Cancer
Jacouton, E., Chain, F., Sokol, H., Langella, P., & Bermúdez-Humarán, L. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01553 · Cited by 249 · cited 1×
“(151) found that Lactobacillus casei BL23 inhibited CAC development, reduced colonic IL-22 concentration, and increased caspase-7, -9, and Bik expression to promote apoptosis in the AOM-DSS–induced CAC model in mice.”
BackgroundHuman colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic
Tomkovich, S., Dejea, C. M., Winglee, K., Drewes, J. L., Chung, L., Housseau, F., Pope, J. L., Gauthier, J., Sun, X., Mühlbauer, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124196 · Cited by 209 · cited 1×
“(60) demonstrated that mucus-invasive bacterial biofilms from both CRC patients and healthy participants are carcinogenic in different CRC models in mice.”
BackgroundMonagas, M., Khan, N., Andres-Lacueva, C., Casas, R., Urpí-Sardà, M., Llorach, R., Lamuela-Raventós, R. M., & Estruch, R. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27716 · Cited by 209 · cited 1×
“For instance, 3,4-dihydroxyphenylpropionic acid (hydrocaffeic acid), which is a major gut microbe–producing metabolite of caffeic acid and chlorogenic acid in the colon, has been shown to inhibit LPS-stimulated TNF-α, IL-1β , and IL-6 in peripheral blood mononuclear cells isolated from healthy volunteers (169).”
BackgroundIshikawa, H., Matsumoto, S., Ohashi, Y., Imaoka, A., Setoyama, H., Umesaki, Y., Tanaka, R., & Otani, T. (2011) · Digestion · doi:10.1159/000322977 · Cited by 197 · cited 1×
“, multiple clinical trials and animal studies have demonstrated their anti-colitis effects in the form of fermented milk products (153), synbiotics (154, 155), or single strains (156), while their anti-CAC effects were observed in animal models either alone (157) or mixed with other Lactobacillus strains (158, 159).”
BackgroundEid, N., Enani, S., Walton, G., Corona, G., Costabile, A., Gibson, G., Rowland, I., & Spencer, J. P. E. (2014) · Journal of Nutritional Science · doi:10.1017/jns.2014.16 · Cited by 192 · cited 3×
“However, these researchers observed an increase in Bifidobacterium by polyphenol-rich palm date extract in the ex vivo incubation study (71).”
BackgroundThe human microbiome: A hot spot of microbial horizontal gene transfer
Liu, L., Chen, X., Skogerbø, G., Zhang, P., Chen, R., He, S., & Huang, D.-W. (2012) · Genomics · doi:10.1016/j.ygeno.2012.07.012 · Cited by 131 · cited 1×
“This is because individual microbes may acquire new functions through horizontal gene transfer among each other (188), and may carry out specific functions under unique host conditions, such as the E.”
BackgroundMicrobiota modification by probiotic supplementation reduces colitis associated colon cancer in mice
Mendes, M. C. S., Paulino, D. S., Brambilla, S. R., Camargo, J. A., Persinoti, G. F., & Carvalheira, J. B. C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i18.1995 · Cited by 116
Cited by
Liu, J., Liang, S., Qin, K., Jia, B., Ren, Z., Yang, X., & Yang, X. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102951 · Cited by 17
Murphy, B. Ó., Latimer, C., Dobani, S., Pourshahidi, L. K., Fontana, M., Ternan, N. G., McDougall, G., Rowland, I., Pereira-Caro, G., Tuohy, K. M., et al. (2024) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2024.2397055
Metadata
- Authors
- Zhao, Y., & Jiang, Q.
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 12
- Issue
- 2
- Pages
- 546-565
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- OpenAlex
- W3084189893
- Cited by
- 180
- References
- 39
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.